Abstract
Summary
The global Bacteriophages (Phage) Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma and APS Biocontrol Ltd. (APS), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
LPI (LP Information)' newest research report, the “Bacteriophages (Phage) Products Industry Forecast” looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2023 through 2029. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segmentation by application
Animal Health
Aquaculture
Agriculture
Food Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma and APS Biocontrol Ltd. (APS), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
LPI (LP Information)' newest research report, the “Bacteriophages (Phage) Products Industry Forecast” looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2023 through 2029. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segmentation by application
Animal Health
Aquaculture
Agriculture
Food Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophages (Phage) Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bacteriophages (Phage) Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bacteriophages (Phage) Products by Country/Region, 2018, 2022 & 2029
2.2 Bacteriophages (Phage) Products Segment by Type
2.2.1 DsDNA Type
2.2.2 SsDNA Type
2.2.3 SsRNA Type
2.2.4 Others
2.3 Bacteriophages (Phage) Products Sales by Type
2.3.1 Global Bacteriophages (Phage) Products Sales Market Share by Type (2018-2023)
2.3.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bacteriophages (Phage) Products Sale Price by Type (2018-2023)
2.4 Bacteriophages (Phage) Products Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Others
2.5 Bacteriophages (Phage) Products Sales by Application
2.5.1 Global Bacteriophages (Phage) Products Sale Market Share by Application (2018-2023)
2.5.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bacteriophages (Phage) Products Sale Price by Application (2018-2023)
3 Global Bacteriophages (Phage) Products by Company
3.1 Global Bacteriophages (Phage) Products Breakdown Data by Company
3.1.1 Global Bacteriophages (Phage) Products Annual Sales by Company (2018-2023)
3.1.2 Global Bacteriophages (Phage) Products Sales Market Share by Company (2018-2023)
3.2 Global Bacteriophages (Phage) Products Annual Revenue by Company (2018-2023)
3.2.1 Global Bacteriophages (Phage) Products Revenue by Company (2018-2023)
3.2.2 Global Bacteriophages (Phage) Products Revenue Market Share by Company (2018-2023)
3.3 Global Bacteriophages (Phage) Products Sale Price by Company
3.4 Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacteriophages (Phage) Products Product Location Distribution
3.4.2 Players Bacteriophages (Phage) Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bacteriophages (Phage) Products by Geographic Region
4.1 World Historic Bacteriophages (Phage) Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Bacteriophages (Phage) Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bacteriophages (Phage) Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bacteriophages (Phage) Products Market Size by Country/Region (2018-2023)
4.2.1 Global Bacteriophages (Phage) Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bacteriophages (Phage) Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bacteriophages (Phage) Products Sales Growth
4.4 APAC Bacteriophages (Phage) Products Sales Growth
4.5 Europe Bacteriophages (Phage) Products Sales Growth
4.6 Middle East & Africa Bacteriophages (Phage) Products Sales Growth
5 Americas
5.1 Americas Bacteriophages (Phage) Products Sales by Country
5.1.1 Americas Bacteriophages (Phage) Products Sales by Country (2018-2023)
5.1.2 Americas Bacteriophages (Phage) Products Revenue by Country (2018-2023)
5.2 Americas Bacteriophages (Phage) Products Sales by Type
5.3 Americas Bacteriophages (Phage) Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophages (Phage) Products Sales by Region
6.1.1 APAC Bacteriophages (Phage) Products Sales by Region (2018-2023)
6.1.2 APAC Bacteriophages (Phage) Products Revenue by Region (2018-2023)
6.2 APAC Bacteriophages (Phage) Products Sales by Type
6.3 APAC Bacteriophages (Phage) Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bacteriophages (Phage) Products by Country
7.1.1 Europe Bacteriophages (Phage) Products Sales by Country (2018-2023)
7.1.2 Europe Bacteriophages (Phage) Products Revenue by Country (2018-2023)
7.2 Europe Bacteriophages (Phage) Products Sales by Type
7.3 Europe Bacteriophages (Phage) Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophages (Phage) Products by Country
8.1.1 Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bacteriophages (Phage) Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Bacteriophages (Phage) Products Sales by Type
8.3 Middle East & Africa Bacteriophages (Phage) Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products
10.3 Manufacturing Process Analysis of Bacteriophages (Phage) Products
10.4 Industry Chain Structure of Bacteriophages (Phage) Products
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacteriophages (Phage) Products Distributors
11.3 Bacteriophages (Phage) Products Customer
12 World Forecast Review for Bacteriophages (Phage) Products by Geographic Region
12.1 Global Bacteriophages (Phage) Products Market Size Forecast by Region
12.1.1 Global Bacteriophages (Phage) Products Forecast by Region (2024-2029)
12.1.2 Global Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bacteriophages (Phage) Products Forecast by Type
12.7 Global Bacteriophages (Phage) Products Forecast by Application
13 Key Players Analysis
13.1 Proteon Pharmaceuticals
13.1.1 Proteon Pharmaceuticals Company Information
13.1.2 Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications
13.1.3 Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Proteon Pharmaceuticals Main Business Overview
13.1.5 Proteon Pharmaceuticals Latest Developments
13.2 Phagelux
13.2.1 Phagelux Company Information
13.2.2 Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications
13.2.3 Phagelux Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Phagelux Main Business Overview
13.2.5 Phagelux Latest Developments
13.3 Intralytix
13.3.1 Intralytix Company Information
13.3.2 Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.3.3 Intralytix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Intralytix Main Business Overview
13.3.5 Intralytix Latest Developments
13.4 Micreos
13.4.1 Micreos Company Information
13.4.2 Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications
13.4.3 Micreos Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Micreos Main Business Overview
13.4.5 Micreos Latest Developments
13.5 Eliava BioPreparations
13.5.1 Eliava BioPreparations Company Information
13.5.2 Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications
13.5.3 Eliava BioPreparations Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eliava BioPreparations Main Business Overview
13.5.5 Eliava BioPreparations Latest Developments
13.6 Locus Biosciences,Inc
13.6.1 Locus Biosciences,Inc Company Information
13.6.2 Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications
13.6.3 Locus Biosciences,Inc Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Locus Biosciences,Inc Main Business Overview
13.6.5 Locus Biosciences,Inc Latest Developments
13.7 Pharmex Group,LLC
13.7.1 Pharmex Group,LLC Company Information
13.7.2 Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications
13.7.3 Pharmex Group,LLC Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pharmex Group,LLC Main Business Overview
13.7.5 Pharmex Group,LLC Latest Developments
13.8 Pherecydes Pharma
13.8.1 Pherecydes Pharma Company Information
13.8.2 Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications
13.8.3 Pherecydes Pharma Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pherecydes Pharma Main Business Overview
13.8.5 Pherecydes Pharma Latest Developments
13.9 APS Biocontrol Ltd. (APS)
13.9.1 APS Biocontrol Ltd. (APS) Company Information
13.9.2 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications
13.9.3 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 APS Biocontrol Ltd. (APS) Main Business Overview
13.9.5 APS Biocontrol Ltd. (APS) Latest Developments
13.10 Qingdao Phagepharm Bio-tech
13.10.1 Qingdao Phagepharm Bio-tech Company Information
13.10.2 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications
13.10.3 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qingdao Phagepharm Bio-tech Main Business Overview
13.10.5 Qingdao Phagepharm Bio-tech Latest Developments
13.11 Fixed-Phage Limited
13.11.1 Fixed-Phage Limited Company Information
13.11.2 Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications
13.11.3 Fixed-Phage Limited Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Fixed-Phage Limited Main Business Overview
13.11.5 Fixed-Phage Limited Latest Developments
13.12 Zeptometrix
13.12.1 Zeptometrix Company Information
13.12.2 Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.12.3 Zeptometrix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zeptometrix Main Business Overview
13.12.5 Zeptometrix Latest Developments
13.13 Phage International, Inc.
13.13.1 Phage International, Inc. Company Information
13.13.2 Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.13.3 Phage International, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Phage International, Inc. Main Business Overview
13.13.5 Phage International, Inc. Latest Developments
13.14 MicroMir
13.14.1 MicroMir Company Information
13.14.2 MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications
13.14.3 MicroMir Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 MicroMir Main Business Overview
13.14.5 MicroMir Latest Developments
13.15 iNtODEWORLD, Inc.
13.15.1 iNtODEWORLD, Inc. Company Information
13.15.2 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.15.3 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 iNtODEWORLD, Inc. Main Business Overview
13.15.5 iNtODEWORLD, Inc. Latest Developments
13.16 NEXTBIOTICS
13.16.1 NEXTBIOTICS Company Information
13.16.2 NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications
13.16.3 NEXTBIOTICS Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 NEXTBIOTICS Main Business Overview
13.16.5 NEXTBIOTICS Latest Developments
13.17 Armata Pharmaceuticals, Inc.
13.17.1 Armata Pharmaceuticals, Inc. Company Information
13.17.2 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.17.3 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Armata Pharmaceuticals, Inc. Main Business Overview
13.17.5 Armata Pharmaceuticals, Inc. Latest Developments
13.18 Innophage
13.18.1 Innophage Company Information
13.18.2 Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.18.3 Innophage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Innophage Main Business Overview
13.18.5 Innophage Latest Developments
13.19 Adaptive Phage Therapeutics
13.19.1 Adaptive Phage Therapeutics Company Information
13.19.2 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications
13.19.3 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Adaptive Phage Therapeutics Main Business Overview
13.19.5 Adaptive Phage Therapeutics Latest Developments
13.20 TechnoPhage
13.20.1 TechnoPhage Company Information
13.20.2 TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.20.3 TechnoPhage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 TechnoPhage Main Business Overview
13.20.5 TechnoPhage Latest Developments
14 Research Findings and Conclusion